Guggenheim Maintains Buy on CryoPort, Raises Price Target to $12

Benzinga Newsdesk www.benzinga.com Positive 77.7%

Neg 0% Neu 0% Pos 77.7%

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $11 to $12.

Comments

No comments yet. Be the first!